- Research works
- 31 ▲ 52% vs 2013–17
- Citations
- 674 21.6 per fractional work
- Top-10% rate
- 1.3% record average 16.5%
- Open access
- 56% world 28%
Not ranked overall: GenProMarkers (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 5.4×. Every wedge is a field page.
Which keywords describe research at GenProMarkers (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Radiotherapy, Glioblastoma, Temozolomide, Oxidative Stress, Cancer, Gene Expression and Biomarkers.
- Targeted Therapy
- Prognosis
- Neuroinflammation
- Depression
- Inflammation
- Epidemiology
- Mass Spectrometry
- Biomarkers
- Cancer
- Glioblastoma
- Oxidative Stress
- Immunotherapy
- Radiotherapy
- Temozolomide
- Gene Expression
- Tumor Microenvironment
- Data Analysis
- Aging
- Cell Death
- Machine Learning
- Precision Medicine
- Metastasis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 22 words, with their numbers
- Immunotherapy4▲ 20×5 topics
- Oxidative Stress3▲ 5.4×12 topics
- Radiotherapy3▲ 26×2 topics
- Glioblastoma3▲ 158×1 topic
- Temozolomide3▲ 158×1 topic
- Cancer3▲ 5.9×14 topics
- Gene Expression2▲ 12×7 topics
- Biomarkers2▲ 11×7 topics
- Tumor Microenvironment2▲ 18×6 topics
- Mass Spectrometry2▲ 28×3 topics
- Data Analysis2▲ 16×2 topics
- Epidemiology2▲ 1.18×12 topics
- Aging1▲ 8.8×5 topics
- Inflammation1▲ 1.92×9 topics
- Cell Death1▲ 19×2 topics
- Depression1▲ 4.6×3 topics
- Machine Learning1▲ 1.61×2 topics
- Neuroinflammation1▲ 13×4 topics
- Precision Medicine1▲ 11×2 topics
- Prognosis1▲ 11×4 topics
- Metastasis1▲ 9.6×4 topics
- Targeted Therapy1▲ 15×3 topics
Which research topics does GenProMarkers (United States) publish most on?
By volume in 2022–2025: Glioma Diagnosis and Treatment, Dermatology and Skin Diseases, Cancer Genomics and Diagnostics and Skin Protection and Aging.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Glioma Diagnosis and Treatment Genetics 2 works
- 2 Dermatology and Skin Diseases Dermatology 0 works
- 3 Cancer Genomics and Diagnostics Cancer Research 0 works
- 4 Skin Protection and Aging Dermatology 0 works
- 5 Neuroblastoma Research and Treatments Neurology 0 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 7 Cancer Research and Treatments Biotechnology 0 works
- 8 Medical and Biological Ozone Research Pharmacology 0 works
- 9 Nutrition and Health in Aging Physiology 0 works
- 10 Photodynamic Therapy Research Studies Pulmonary and Respiratory Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has GenProMarkers (United States)'s research output changed?
Output in 2018–2022 was 52% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rockville
- United States Nuclear Regulatory Commission
- Signal Processing (United States)
- Center for Devices and Radiological Health
- Agency for Healthcare Research and Quality
- Orthopaedic Center
- Biomedical Research Institute
- Westat (United States)
- Research Applications (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.